Company news

Actinogen Medical Limited news in 2019

Actinogen Medical Limited's news releases, calls and decks from 2019, newest first.

View company

ACW 2019 AGM Chairman's Address

November 24, 2019

R&D Tax Incentive rebate received of $4.58 million

October 24, 2019

September 2019 Quarterly Update

October 23, 2019

Cognitive improvement demonstrated with Xanamem

October 1, 2019

June 2019 Quarterly Update

July 29, 2019

Xanamen Clinical Development & Investor Update

June 25, 2019

XanaHES Trial to Continue

May 28, 2019

Phase II Alzheimers Disease Trial - results

May 7, 2019

March 2019 Quarterly Update

April 23, 2019

New Clinical Development Opportunities for Xanamem

April 9, 2019

DSMB again reaffirms XanADu trial to continue without change

March 25, 2019

1st participant dosed in important new Xanamem study-XanaHES

February 10, 2019

December 2018 Quarterly Update

January 28, 2019

Decks in 2019